日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Dual-Oriented Targeted Nanostructured SERS Label-Free Immunosensor for Detection, Quantification, and Analysis of Breast Cancer Biomarker Concentrations in Blood Serum.

双取向靶向纳米结构SERS无标记免疫传感器用于检测、定量和分析血清中乳腺癌生物标志物浓度

期刊:Biosensors-Basel
影响因子:5.6
doi:10.3390/bios15070447
Khosroshahi Mohammad E, Gaoiran Christine, Umashanker Vithurshan, Veeru Hayagreev, Panday Pranav
肿瘤
乳腺癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Semaglutide 2.4 mg Clinical Outcomes in Patients with Obesity or Overweight: A Real-World Retrospective Comparative Cohort Study

索玛鲁肽 2.4 mg 在肥胖或超重患者中的临床疗效：一项真实世界回顾性比较队列研究

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-025-03320-6
Ruseva, Aleksandrina; Michalak, Wojciech; Fabricatore, Anthony; Hartaigh, Bríain Ó; Zhao, Zhenxiang; Umashanker, Devika
肥胖
代谢
发表日期：2025
文献求助 收藏

EGFR molecular degraders: preclinical successes and the road ahead

EGFR分子降解剂：临床前研究的成功与展望

期刊:Future Medicinal Chemistry
影响因子:3.4
doi:10.1080/17568919.2025.2463871
Rallabandi, Naveen Chand; Panpatil, Dayanand; Gahtory, Digvijay; Navik, Umashanker; Kumar, Raj
EGFR
EGF
发表日期：2025
文献求助 收藏

Semaglutide 2.4 mg clinical outcomes in patients with obesity or overweight in a real-world setting: A 6-month retrospective study in the United States (SCOPE)

真实世界中肥胖或超重患者使用司美格鲁肽 2.4 mg 的临床疗效：一项在美国进行的为期 6 个月的回顾性研究 (SCOPE)

期刊:Obesity Science & Practice
影响因子:1.9
doi:10.1002/osp4.737
Ruseva, Aleksandrina; Michalak, Wojciech; Zhao, Zhenxiang; Fabricatore, Anthony; Hartaigh, Bríain Ó; Umashanker, Devika
肥胖
代谢
发表日期：2024
文献求助 收藏

Targeted FT-NIR and SERS Detection of Breast Cancer HER-II Biomarkers in Blood Serum Using PCB-Based Plasmonic Active Nanostructured Thin Film Label-Free Immunosensor Immobilized with Directional GNU-Conjugated Antibody

使用定向 GNU 偶联抗体固定的基于 PCB 的等离子体活性纳米结构薄膜无标记免疫传感器对血清中的乳腺癌 HER-II 生物标志物进行靶向 FT-NIR 和 SERS 检测

期刊:Sensors
影响因子:
doi:10.3390/s24165378
Mohammad E Khosroshahi, Yesha Patel, Vithurshan Umashanker
肿瘤
乳腺癌
发表日期：2024
文献求助 收藏

Antimicrobial and anti-viral effects of selenium nanoparticles and selenoprotein based strategies: COVID-19 and beyond

硒纳米颗粒和硒蛋白基策略的抗菌和抗病毒作用：COVID-19及其他

期刊:Journal of Drug Delivery Science and Technology
影响因子:4.9
doi:10.1016/j.jddst.2023.104663
Khurana, Amit; Allawadhi, Prince; Singh, Vishakha; Khurana, Isha; Yadav, Poonam; Sathua, Kshirod Bihari; Allwadhi, Sachin; Banothu, Anil Kumar; Navik, Umashanker; Bharani, Kala Kumar
微生物学
发表日期：2023
文献求助 收藏

Dynamin-Independent Mechanisms of Endocytosis and Receptor Trafficking

内吞作用和受体运输的动力蛋白非依赖性机制

期刊:Cells
影响因子:5.2
doi:10.3390/cells11162557
Gundu, Chayanika; Arruri, Vijay Kumar; Yadav, Poonam; Navik, Umashanker; Kumar, Ashutosh; Amalkar, Veda Sudhir; Vikram, Ajit; Gaddam, Ravinder Reddy
信号转导
发表日期：2022
文献求助 收藏

Synthesis, biological evaluation and in-silico ADME studies of novel series of thiazolidin-2,4-dione derivatives as antimicrobial, antioxidant and anticancer agents

合成、生物学评价和计算机模拟ADME研究新型噻唑烷-2,4-二酮衍生物作为抗菌剂、抗氧化剂和抗癌剂

期刊:BMC Chemistry
影响因子:4.6
doi:10.1186/s13065-022-00861-7
Kumar, Harsh; Kumar, Davinder; Kumar, Pradeep; Thareja, Suresh; Marwaha, Minakshi Gupta; Navik, Umashanker; Marwaha, Rakesh Kumar
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Targeting mitochondrial bioenergetics as a promising therapeutic strategy in metabolic and neurodegenerative diseases

靶向线粒体生物能量学是治疗代谢性疾病和神经退行性疾病的一种有前景的治疗策略。

期刊:Biomedical Journal
影响因子:4.4
doi:10.1016/j.bj.2022.05.002
Bhatti, Gurjit Kaur; Gupta, Anshika; Pahwa, Paras; Khullar, Naina; Singh, Satwinder; Navik, Umashanker; Kumar, Shashank; Mastana, Sarabjit Singh; Reddy, Arubala P; Reddy, P Hemachandra; Bhatti, Jasvinder Singh
线粒体
神经科学
代谢
发表日期：2022
文献求助 收藏

Experienced weight stigma, internalized weight bias, and clinical attrition in a medical weight loss patient sample

在医疗减肥患者样本中，经历体重歧视、内化体重偏见和临床流失的情况

期刊:International Journal of Obesity
影响因子:3.8
doi:10.1038/s41366-022-01087-2
Verhaak, Allison M S; Ferrand, Jennifer; Puhl, Rebecca M; Tishler, Darren S; Papasavas, Pavlos K; Umashanker, Devika
发表日期：2022
文献求助 收藏